Growth in children and adolescents with sickle cell disease in Yemen

Annals of Tropical Paediatrics

Volumn 30, Issue 4, 2010, Pages 287-298

  Al Saqladi, A W M ^a   Bin Gadeen, H A ^a   Brabin, B J ^b,c,d  

^a Aden University   (Yemen)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE;

ADOLESCENT; ANTHROPOMETRY; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; GROWTH DISORDER; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SCHOOL CHILD; SCORING SYSTEM; SICKLE CELL ANEMIA; WORLD HEALTH ORGANIZATION; YEMEN;

ADOLESCENT; ANEMIA, SICKLE CELL; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; GROWTH DISORDERS; HUMANS; INFANT; MALE; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; YEMEN;

EID: 78649677082     PISSN: 02724936     EISSN: 14653281     Source Type: Journal    
DOI: 10.1179/146532810X12858955921113     Document Type: Article

References (40)

1. Al-Saqladi AW, Cipolotti R, Fijnvandraat K, Brabin BJ. Growth and nutritional status of children with homozygous sickle cell disease. Ann Trop Paediatr 2008; 28:165-89.
2. Serjeant GR. Sickle CellDisease, 3rd edn. New York: Oxford University Press, 2001.
3. Fung EB, Malinauskas BM, Kawchak DA, et al. Energy expenditure and intake in children with sickle cell disease during acute illness. Clin Nutr 2001; 20:131-8.
4. Malinauskas BM, Gropper SS, Kawchak DA, Zemel BS, Ohene-Frempong K, Stallings VA. Impact of acute illness on nutritional status of infants and young children with sickle cell disease. JAm DietAssoc 2000; 100:330-4.
5. Akohoue SA, Shankar S, Milne GL, et al. Energy expenditure, inflammation, and oxidative stress in steady-state adolescents with sickle cell anemia. PediatrRes 2007; 61:233-8.
6. Gokhale R, Kirschner BS. Transition of care between paediatric and adult gastroenterology. Assessment of growth and nutrition. Best Pract Res Clin Gastroenterol2003; 17:153-62.
7. Gill FM, Sleeper LA, Weiner SJ, et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Blood 1995; 86:776-83.
8. Al-Saqladi A, Delpisheh A, Bin-Gadeem H, Brabin BJ. Clinical profile of sickle cell disease in Yemeni children. Ann Trop Paediatr 2007; 27:253-9.
9. El-Hazmi MAF. Clinical and haematological diver-sity of sickle cell disease in Saudi children. J Trop Pediatr 1992; 38:106-12.
10. Al-Saqladi A, Delpisheh A, Bin-Gadeem H, Brabin BJ. Severity of sickle cell disease in Yemeni children. J Trop Pediatr 2009; 55:208-9.
11. World Health Organization. Growth Standards: Length/Height-for-Age, Weight-for-Age, Weight-for-Length, Weight-for-Height and Body Mass Index-for-Age: Methods and Development. Geneva: WHO, www.who.int/childgrowth/ standards, 2006.
12. World Health Organization. Growth Reference Data for Children From 5 to 19 Years. Geneva: WHO, 2007, www.who.int/growthref/en/.
13. Sunil TS. Effects of socio-economic and beha-vioural factors on childhood malnutrition in Yemen. Matern Child Nutr 2009; 5:251-9.
14. Thomas PW, Singhal A, Hemmings-Kelly M, Serjeant GR. Height and weight reference curves for homozygous sickle cell disease. Arch Dis Child 2000; 82:204-8.
15. World Health Organization. PhysicalStatus: The Use and Interpretation of Anthropometry. Report of a WHO Expert Committee, tech. rep. series 854. Geneva: WHO, 1995.
16. de Onis M, Garza C, Onyango AW, Borghi E. Comparison of the WHO child growth standards and the CDC 2000 growth charts. J Nutr 2007; 137:144-8.
17. Duggan MB. Anthropometry as a tool for measur-ing malnutrition: impact of the new WHO growth standards and reference. Ann Trop Paediatr 2010; 30:1-17.
18. Perrine RP, John P, Pembrey M, Perrine S. Sickle cell disease in Saudi Arabs in early childhood. Arch Dis Child 1981; 56:187-92.
19. Jaiyesimi F, Pandey R,BuxD, Sreekrishna Y, Zaki F, Krishnamoorthy N. Sickle cell morbidity profile in Omani children. Ann Trop Paediatr 2002; 22:45-52.
20. Silva CM, Viana MB. Growth deficits in children with sickle cell disease. Arch Med Res 2002; 33:308-12.
21. Zemel BS, Kawchak DA, Ohene-Frempong K, Schall JI, Stallings VA. Effects of delayed pubertal development, nutritional status, and disease severity on longitudinal patterns of growth failure in children with sickle cell disease. Pediatr Res 2007; 61:607-13.
22. Barden EM, Kawchak DA, Ohene-Frempong K, Stallings VA, Zemel BS. Body composition in children with sickle cell disease. Am J Clin Nutr 2002; 76:218.
23. Borel MJ, Buchowski MS, Turner EA, Goldstein RE, Flakoll PJ. Protein turnover and energy expenditure increase during exogenous nutrient availability in sickle cell disease. Am J Clin Nutr 1998; 68:607-14.
24. Singhal A, Davies P, Sahota A, Thomas PW, Serjeant GR. Resting metabolic rate in homozygous sickle cell disease. Am J Clin Nutr 1993; 57:32-4.
25. Singhal A, Davies P, Wierenga KJ, Thomas P, Serjeant G. Is there an energy deficiency in homozygous sickle cell disease? Am J Clin Nutr 1997; 66:386-90.
26. Buchanan JB, Johnson RW. Regulation of food intake by inflammatory cytokines in the brain. Neuroendocrinology 2007; 86:183-90.
27. Brittain JE, Parise LV. Cytokines and plasma factors in sickle cell disease. Curr Opin Hematol 2007; 14:438-43.
28. Al-Saqladi AW, Bin-Gadeem HA, Brabin BJ. Utility of plasma transferrin receptor, ferritin and inflammatory markers in children with sickle cell disease (submitted).
29. Singhal A, Doherty JF, Raynes JG, et al. Is there an acute-phase response in steady-state sickle cell disease? Lancet 1993; 341:651-3.
30. Hibbert JM, Hsu LL, Bhathena SJ et al. Proinflammatory cytokines and the hypermetabo-lism of children with sickle cell disease. Exp Biol Med (Maywood) 2005; 230:68-74.
31. Wang WC, Morales KH, Scher CD, et al. Effect of long-term transfusion on growth in children with sickle cell anemia: results of the STOP trial. JPediatr 2005; 147:244-7.
32. Badaloo A, Emond A, Venugopal S, Serjeant G, Jackson AA. The effect of splenectomy on whole body protein turnover in homozygous sickle cell disease. Acta Paediatr Scand 1991; 80:103-5.
33. Singhal A, Thomas P, Kearney T, Venugopal S, Serjeant G. Acceleration in linear growth after splenectomy for hypersplenism in homozygous sickle cell disease. Arch Dis Child 1995; 72:227-9.
34. Fung EB, Barden EM, Kawchak DA, Zemel BS, Ohene-Frempong K, Stallings VA. Effect of hydro-xyurea therapy on resting energy expenditure in children with sickle cell disease. J Pediatr Hematol Oncol 2001; 23:604-8.
35. Hankins JS, Helton KJ, McCarville MB, Li CS, Wang WC, Ware RE. Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea. Pediatr Blood Cancer 2008; 50:293-7.
36. Pellegrini-Braga J, Kerbauy J, Fisberg M. Zinc, cooper and iron and their interrelations in the growth of sickle cell patients [Zinc, cobre, hierro y su interrelación con el crescimiento de niños con anemia falciforme]. Arch Latinoam Nutr 1995; 45:198-203.
37. Singhal A, Morris J, Thomas P, Dover G, Higgs D, Serjeant G. Factors affecting prepubertal growth in homozygous sickle cell disease. Arch Dis Child 1996; 74:502-6.
38. Lowry MF, Desai P, Ashcroft MT, Serjeant BF, Serjeant GR. Heights and weights of Jamaican children with homozygous sickle cell disease. Hum Biol 1977; 49:429-36.
39. Fung EB, Kawchak DA, Zemel BS, Rovner AJ, Ohene-Frempong K, Stallings VA. Markers ofbone turnover are associated with growth and develop-ment in young subjects with sickle cell anemia. Pediatr Blood Cancer 2008; 50:620-3.
40. Bain BJ. Neonatal/newborn haemoglobinopathy screening in Europe and Africa. J Clin Pathol 2009; 62:53-6.